Renaissance Investment Consultants Holding Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Renaissance Investment Consultants Holding Company’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$291K	Buy	4,399 +7	+0.2%	+$457	0.27%	64
2020 Q2	$289K	Buy	4,392 +9	+0.2%	+$559	0.32%	62
2020 Q1	$241K	Sell	4,383 -172	-4%	-$10.5K	0.34%	69
2019 Q4	$293K	Buy	+4,555	New	+$277K	0.33%	75

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

AWMS

Advocacy Wealth Management Services Atlanta, Georgia $2.75B AUM 19.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Investment Consultants Holding Company's PJP Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.16% in Q3 2020, buying an estimated $457 and bringing the position to 4,399 shares worth $291K. The position accounts for 0.27% of the portfolio, ranked #64.

Renaissance Investment Consultants Holding Company first reported a position in PJP in Q4 2019 and has held it in 4 quarters since. The position peaked at $293K in Q4 2019. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2020.

Renaissance Investment Consultants Holding Company held 4,399 shares of Invesco Pharmaceuticals ETF worth $291K as of Q3 2020.
Renaissance Investment Consultants Holding Company bought 7 Invesco Pharmaceuticals ETF shares in Q3 2020, an estimated $457.
Invesco Pharmaceuticals ETF made up 0.27% of Renaissance Investment Consultants Holding Company's portfolio in Q3 2020, its #64 holding.
Renaissance Investment Consultants Holding Company first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 4 quarters since.
Renaissance Investment Consultants Holding Company's Invesco Pharmaceuticals ETF position peaked at $293K in Q4 2019.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.